Lipocine's LPCN 1154 Phase 3 Results to Be Featured at 2026 ASCP Annual Meeting#United_States#Miami#Lipocine#LPCN_1154#ASCP_Meeting
Lipocine's LPCN 1154 Phase 3 Results to Be Featured at 2026 ASCP Annual Meeting
Lipocine's LPCN 1154 Phase 3 clinical trial results will be shared at the upcoming 2026 ASCP Annual Meeting, addressing postpartum depression.
third-news.com
May 19, 2026 at 12:40 PM
Lipocine's LPCN 1154 Phase 3 Results to Be Featured at 2026 ASCP Annual Meeting#United_States#Miami#Lipocine#LPCN_1154#ASCP_Meeting